Search

everythinglearnresearchcommunity

for

Search:↓

Hair papilla cells are crucial for blood vessel development in hair follicles, affecting hair growth and loss.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

New research is helping develop better treatments for alopecia areata.

The document concluded that stem cells are crucial for skin repair, regeneration, and may help in developing advanced skin substitutes.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Finasteride helps female-pattern hair loss.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

The biofilm-dispersing wound gel helps wounds heal faster and prevents infection.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Tph cells are linked to the severity of systemic lupus erythematosus.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Ruxolitinib can cause a delayed skin reaction on the nose.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Melatonin improves cashmere goat hair quality by increasing follicles and reducing skin aging.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The substance DMC helps get rid of aging cells by triggering a process that causes cell death, which could treat age-related diseases.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The reviewers suggest clarifying and expanding on the role of inflammation in stem cell-related cancer development.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.